RKDA vs FMC

For growth investors, Arcadia Biosciences, Inc.

(RKDA) is the stronger pick with -3. 7% revenue growth year-over-year, versus -18. 3% for FMC Corporation (FMC). Analysts rate FMC Corporation (FMC) a "Hold" — based on 42 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, FMC Corporation (FMC) delivered a total return of -80.

2%, compared to -98. 9% for Arcadia Biosciences, Inc. (RKDA). Over 10 years, the gap is even starker: FMC returned -26. 8% versus RKDA's -99. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Arcadia Biosciences, Inc.

(RKDA) is the lower-risk stock at 0. 98β versus FMC Corporation's 1. 63β — meaning FMC is approximately 65% more volatile than RKDA relative to the S&P 500.

By revenue growth (latest reported year), Arcadia Biosciences, Inc.

(RKDA) is pulling ahead at -3. 7% versus -18. 3% for FMC Corporation (FMC). On earnings-per-share growth, the picture is similar: Arcadia Biosciences, Inc. grew EPS 66. 9% year-over-year, compared to -757. 4% for FMC Corporation. Over a 3-year CAGR, RKDA leads at -13. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Arcadia Biosciences, Inc.

(RKDA) is the more profitable company, earning -48. 1% net margin versus -64. 6% for FMC Corporation — meaning it keeps -48. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: FMC leads at -54. 4% versus -205. 7% for RKDA. At the gross margin level — before operating expenses — FMC leads at 37. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

In this comparison, FMC (17.

0% yield) pays a dividend. RKDA does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Arcadia Biosciences, Inc.

(RKDA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 98)). FMC Corporation (FMC) carries a higher beta of 1. 63 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (RKDA: -99. 9%, FMC: -26. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: RKDA is a small-cap quality compounder stock; FMC is a small-cap income-oriented stock. FMC pays a dividend while RKDA does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.